Skip to main content
. 2013 Jan 23;141(11):2384–2391. doi: 10.1017/S0950268813000010

Table 2.

Distribution of MRSA and MR-CoNS isolates among 227 study volunteer subjects

Subjects carrying MRSA Subjects carrying MR-CoNS
n (%) n (%)
Total 19 (8·4) 123 (54·2)
Total nasal 17 (7·5) 110 (48·5)
Total skin 13 (5·7) 28 (12·3)
Exclusively nasal 6 (2·6) 95 (41·8)
Exclusively skin 2 (0·9) 13 (5·7)
Nasal + skin 11 (4·8) 15 (6·6)

MRSA, Methicillin-resistant Staphylococcus aureus; MR-CoNS, methicillin-resistant coagulase-negative staphylococci.